SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulfs better-than-expected quarterly results and Googles credit support for financing tied to its Anthropic data-center lease are driving attention. Bulls see the financing and AI infrastructure demand as supportive, while skeptics point to the stocks weak reaction, heavy debt, construction execution risks, and uncertainty around data-center regulation.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings sharp selloff follows a Q3 earnings miss and a steep cut to its full-year outlook, with heavy investment in its Predictions business cited as a major drag on expected profitability. Traders are broadly criticizing management, spending and competitive pressures from prediction-market rivals, while some argue the core sportsbook remains healthy and are buying the drop.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Fireflys multi-year agreement to supply rocket engines, licensed technology, and engineering support for AST SpaceMobiles heavy-lift rocket is drawing attention. Traders largely view the deal as a major commercial validation and potential boost to Fireflys backlog and funding, while some question the execution demands and what the arrangement means for ASTs launch plans.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobiles Firefly engine agreement and plan to develop its own heavy-lift rocket have sparked debate over whether greater control of satellite launches can ease a key bottleneck. Traders are split between viewing the move as a long-term strategic step and worrying about its cost, execution risk, and potential dilution.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklos rebound is drawing attention after its Q3 business update and a manufacturing agreement reserving capacity for future Aurora reactor components. Bulls see the agreement as progress, while skeptics point to minimal current revenue, long commercialization timelines, and dilution and valuation concerns.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is drawing attention after strong quarterly results and raised growth guidance were followed by a sharp share-price decline. Traders are debating the disconnect, with some citing a Craig-Hallum price-target cut and others calling the selloff an overreaction or alleging trading pressure.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS is drawing attention as traders await topline survival results from the Phase 3 REGAL trial of its AML drug candidate GPS; the community says the trial reached its 80th event and is in final analysis, with results expected this quarter. Optimism about the readout and separate SLS009 data is running against concern over the sharp share-price decline, with traders debating whether it reflects broad-market pressure or doubts about the company and its prospects.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. It operates through the Hard Disk Drives (HDD) segment. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Concerns that political opposition could slow U.S. data-center construction have fueled selling in AI-related storage and semiconductor stocks, including WDC. Traders debate whether that risk threatens storage demand: bears see a possible buildout slowdown, while bulls point to strong company results and ongoing demand for data storage.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

Rigels quarterly results have sparked a sharp selloff, with traders focused on an earnings shortfall and concerns about profitability and legacy-product trends despite VEPPANUs promising early launch. Bulls point to VEPPANUs growth potential and upcoming R289 data, while bears question how quickly the new drug can offset pressure on older products.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas stronger-than-expected quarterly results and raised revenue outlook, supported by vaccine sales, are driving attention. Traders are split over whether the improved results and pipeline prospects justify the valuation, with skeptics pointing to cash burn and a sharp sell-the-news reversal after the initial rally.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Richard Nguyen

Whale

Tuna T

anh vo

LIVIMMUNE Bound

Joe Blow

Timothy OConnor

Gordon Skorstad

Steven feldman

Tomleon

christopher

Am coan

Richard

dudu8888

mitchmiller

Mike

Jake

renesantiago

vivamiga

StockTwits for iOS

CytoDyn Inc

Chris Knight

@RealGenius 
I don’t care what any of you think.  
You don’t have to like him but I am thankful and feel blessed to have him in office.   We were in trouble otherwise.   
I hope the little guys get their shot because at this point they have been beaten back by big pharma.  Will I take a hit with big pharma stocks - yes likely but it is the right thing to do.  A no brainer. I am in medical field and see the denials each day.   Thank you DT for trying your best in a job where you will face / have faced and continue to face much unwarranted scrutiny.  
Love Cydy 
I know DT and RFK  and the world will know the name Leronlimab in a short time.

 
I don’t care what any of you think.  
You don’t have to like him but I am thankful and feel blessed to have him in office.   We were in trouble otherwise.   
I hope the little guys get their shot because at this point they have been beaten back by big pharma.  Will I take a hit with big pharma stocks - yes likely but it is the right thing to do.  A no brainer. I am in medical field and see the denials each day.   Thank you DT for trying your best in a job where you will face / have faced and continue to face much unwarranted scrutiny.  
Love Cydy 
I know DT and RFK  and the world will know the name Leronlimab in a short time.

@RealGenius This EO really speaks to needing LL as the SOC in every countries pharma market.....

StockTwits Web

 This EO really speaks to needing LL as the SOC in every countries pharma market.....

@RealGenius 
Thanks 
I just gave a long post -‘perhaps deleted 
I thanked DT.  These guys are doing the right thing.

 
Thanks 
I just gave a long post -‘perhaps deleted 
I thanked DT.  These guys are doing the right thing.

@RealGenius The pharmaceutical sector stock market is about to plunge! Hopefully massive amounts of investors and traders will dump their holdings in these blue chip BP’s and begin to invest in an yocomer like CYDY. I hope this move doesn’t affect Partnerships. I can scenarios where it might help a partnership agreement with CYDY and certainly can see where it might stall an agreement. Overall, the policy is very favorable to the U.S. citizens and to the Medicare budget!

 The pharmaceutical sector stock market is about to plunge! Hopefully massive amounts of investors and traders will dump their holdings in these blue chip BP’s and begin to invest in an yocomer like CYDY. I hope this move doesn’t affect Partnerships. I can scenarios where it might help a partnership agreement with CYDY and certainly can see where it might stall an agreement. Overall, the policy is very favorable to the U.S. citizens and to the Medicare budget!